🇺🇸 FDA
Patent

US 11753397

Cereblon binders for the degradation of ikaros

granted A61PA61P29/00A61P35/00

Quick answer

US patent 11753397 (Cereblon binders for the degradation of ikaros) held by C4 THERAPEUTICS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P29/00, A61P35/00, A61P37/00